Several approaches aiming at restoring TTP expression in cancer cells have been proposed, such as DNA demethylating agents in hepatocellular carcinoma or histone deacetylase inhibitors (HDAC) in colorectal cancer and HCC [152,156]. This evidence concerns the gene ZFP36 and hepatocellular carcinoma.